1. Repository of OAI
Ελληνικά   English  

Browsing by Author Briasoulis, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 112 to 126 of 126 < previous 
TitleAuthor(s)Issue date???itemlist.???
Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancerBriasoulis, E.; Liakakos, T.; Dova, L.; Fatouros, M.; Tsekeris, P.; Roukos, D. H.; Kappas, A. M.24-Nov-2015-
Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemiaTsiara, S.; Christou, L.; Konstantinidou, P.; Panteli, A.; Briasoulis, E.; Bourantas, K. L.24-Nov-2015-
Successful rechallenge with taxanes following prophylactic ketotifen in patients who had developed severe hypersensitivity reactionsBriasoulis, E.; Karavasilis, V.; Pavlidis, N.24-Nov-2015-
Syndrome of inappropriate antidiuretic hormone secretion due to recurrent oral cancerDanielides, V.; Milionis, H. J.; Karavasilis, V.; Briasoulis, E.; Elisaf, M. S.24-Nov-2015-
Targeting Oncogenic Protein-Protein Interactions by Diversity Oriented Synthesis and Combinatorial Chemistry ApproachesFokas, D.; Briasoulis, E.; Johannes, C.; Moussis, V.; Hatzimichael, E.; Tzakos, A. G.24-Nov-2015-
Targeting Oncogenic Protein-Protein Interactions by Diversity Oriented Synthesis and Combinatorial Chemistry ApproachesTzakos, A. G.; Fokas, D.; Johannes, C.; Moussis, V.; Hatzimichael, E.; Briasoulis, E.24-Nov-2015-
Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategiesMurray, S.; Briasoulis, E.; Linardou, H.; Bafaloukos, D.; Papadimitriou, C.24-Nov-2015-
Thrombospondin-1 expression in breast cancer: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix componentsIoachim, E.; Damala, K.; Tsanou, E.; Briasoulis, E.; Papadiotis, E.; Mitselou, A.; Charhanti, A.; Doukas, M.; Lampri, L.; Arvanitis, D. L.24-Nov-2015-
Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationChristodoulou, C.; Kostopoulos, I.; Kalofonos, H. P.; Lianos, E.; Bobos, M.; Briasoulis, E.; Gogas, H.; Razis, E.; Skarlos, D. V.; Fountzilas, G.24-Nov-2015-
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use programRazis, E.; Skarlos, D.; Briasoulis, E.; Dimopoulos, M.; Fountzilas, G.; Lambropoulos, S.; Rigatos, S.; Kopterides, P.; Efstathiou, H.; Tzamakou, E.; Bakoyannis, C.; Pectasides, D.; Makatsoris, T.; Varthalitis, G.; Papadopoulos, S.; Kosmidis, P.24-Nov-2015-
Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapyBuxhofer-Ausch, V.; Secky, L.; Wlcek, K.; Svoboda, M.; Kounnis, V.; Briasoulis, E.; Tzakos, A. G.; Jaeger, W.; Thalhammer, T.24-Nov-2015-
Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumabKoutras, A. K.; Antonacopoulou, A. G.; Eleftheraki, A. G.; Dimitrakopoulos, F. I.; Koumarianou, A.; Varthalitis, I.; Fostira, F.; Sgouros, J.; Briasoulis, E.; Bournakis, E.; Bafaloukos, D.; Bompolaki, I.; Galani, E.; Kalogeras, K. T.; Pectasides, D.; Fountzilas, G.; Kalofonos, H. P.24-Nov-2015-
Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology GroupGogas, H.; Bafaloukos, D.; Aravantinos, G.; Fountzilas, G.; Tsoutsos, D.; Panagiotou, P.; Frangia, K.; Kalofonos, H. P.; Briasoulis, E.; Castana, O.; Polyzos, A.; Pectasides, D.; Ioannovich, J.24-Nov-2015-
Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administrationBriasoulis, E.; Karavasilis, V.; Anastasopoulos, D.; Tzamakou, E.; Fountzilas, G.; Rammou, D.; Kostadima, V.; Pavlidis, N.24-Nov-2015-
Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumorsBriasoulis, E.; Pentheroudakis, G.; Karavasilis, V.; Tzamakou, E.; Rammou, D.; Pavlidis, N.24-Nov-2015-
Showing results 112 to 126 of 126 < previous